Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2015

Open Access 01-12-2015 | Meeting abstract

Experimental model of type 2 diabetes induced by fat diet consumption and low dose of streptozotocin in C57BL/6J mice

Authors: Mariana de Freitas Moreira, Natalia do Vale Canabrava, Sandra Machado Lira, Tatiane Rodrigues Oliveira, José Ytalo Gomes da Silva, Marcelo Oliveira Holanda, Carla Laíne Silva Lima, Julianne do Nascimento Sales, Arnaldo Solheiro Bezerra, Bruno Bezerra da Silva, Erlândia Alves Magalhães Queiroz, Paula Alves Salmito Rodrigues, Raquel Teixeira Terceiro Paim, Lia Magalhães de Almeida, Maria Izabel Florindo Guedes

Published in: Diabetology & Metabolic Syndrome | Special Issue 1/2015

Login to get access

Excerpt

Studies with murine model have been extensively used as a tool in the understanding of mechanisms involved in diseases such as diabetes (Correia-Santos et al, 2012; Chorilli, 2007). Diabetes is characterized as a heterogeneous group of metabolic disorders having in common hyperglycemia, which may result from defects in insulin action or secretion or even in both. The same can be divided into four groups: type 1 diabetes mellitus (DM1), type 2 diabetes mellitus (DM2), gestational diabetes mellitus, and other specific types of diabetes (SBD, 2014). It is known that DM2 is associated with overweight and obesity, physical inactivity, metabolic syndrome, diet high in saturated and animal fat, among others. (Paulweber et al., 2010). …
Metadata
Title
Experimental model of type 2 diabetes induced by fat diet consumption and low dose of streptozotocin in C57BL/6J mice
Authors
Mariana de Freitas Moreira
Natalia do Vale Canabrava
Sandra Machado Lira
Tatiane Rodrigues Oliveira
José Ytalo Gomes da Silva
Marcelo Oliveira Holanda
Carla Laíne Silva Lima
Julianne do Nascimento Sales
Arnaldo Solheiro Bezerra
Bruno Bezerra da Silva
Erlândia Alves Magalhães Queiroz
Paula Alves Salmito Rodrigues
Raquel Teixeira Terceiro Paim
Lia Magalhães de Almeida
Maria Izabel Florindo Guedes
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue Special Issue 1/2015
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/1758-5996-7-S1-A160

Other articles of this Special Issue 1/2015

Diabetology & Metabolic Syndrome 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine